MapLight Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 |
|---|---|---|
Revenue | $0 | $0 |
Gross Profit | -140 | -136 |
EBITDA | -83,237 | -31,362 |
EBIT | -83,377 | -31,498 |
Net Income | -79,548 | -29,418 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -47,205 | -31,822 |
Cash | 46,729 | 64,146 |
Basic Shares | 44,024 | 41,428 |
Annual Financials
| Values in thousands | 2025-12-31 |
|---|---|
Revenue | $0 |
Gross Profit | -578 |
EBITDA | -168,505 |
EBIT | -169,083 |
Net Income | -161,152 |
Net Change In Cash | 0 |
Free Cash Flow | -138,610 |
Cash | 46,729 |
Basic Shares | 44,024 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$2.47 |
2025-09-30 | -$37.18 |
2025-06-30 | -$39.11 |
